Neuroscience
The September 2009 issue of Wired has a nifty little article on the impact of placebo effects on pharmaceutical clinical trials and pharma company decision making: "Real. Fake. Both Can Cure Depression." by Steve Silberman.
===
Addendum on 28th August: As you will see from the comments, this piece is available on Wired magazine's website. You can access it here
===
- Neuropsychology Abstract Of The Day: Modafinil And Fatigue In Depression
Lam JY, Freeman MK, & Gates ME. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Annals of Pharmacotherapy. 2007 Jun;41(6):1005-12. Epub 2007 May 22. University of Alabama Health System-Birmingham,...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...
- Issues In Clinical Trials: Gdnf And Parkinson Disease
Today's New York Times includes a front-page article about the culture of clinical-trials research: what happens to participant subjects when an experimental drug is pulled from testing and, among other issues, how teasing apart placebo-based from...
- Pharmaceutical Clinical Trials: Merck
From The New York Times (06 September 2004; free registration required): Merck Says It Will Post the Results of All Drug Trials By GARDINER HARRIS Merck & Company says it will post the results of its clinical trials on drugs on a Web site run by...
- Splogs = Bad News
An article in the September issue of Wired: Spam + Blogs =Trouble answers the question "why do I have to type 'zvtmzu' to post a comment on your blog?!" Because of splogs & link farms. Blech. Jon Gordon on Future Tense interviewed Charles C. Mann,...
Neuroscience
The Placebo Problem and Clinical Trials
The September 2009 issue of Wired has a nifty little article on the impact of placebo effects on pharmaceutical clinical trials and pharma company decision making: "Real. Fake. Both Can Cure Depression." by Steve Silberman.
===
Addendum on 28th August: As you will see from the comments, this piece is available on Wired magazine's website. You can access it here
===
- Neuropsychology Abstract Of The Day: Modafinil And Fatigue In Depression
Lam JY, Freeman MK, & Gates ME. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Annals of Pharmacotherapy. 2007 Jun;41(6):1005-12. Epub 2007 May 22. University of Alabama Health System-Birmingham,...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...
- Issues In Clinical Trials: Gdnf And Parkinson Disease
Today's New York Times includes a front-page article about the culture of clinical-trials research: what happens to participant subjects when an experimental drug is pulled from testing and, among other issues, how teasing apart placebo-based from...
- Pharmaceutical Clinical Trials: Merck
From The New York Times (06 September 2004; free registration required): Merck Says It Will Post the Results of All Drug Trials By GARDINER HARRIS Merck & Company says it will post the results of its clinical trials on drugs on a Web site run by...
- Splogs = Bad News
An article in the September issue of Wired: Spam + Blogs =Trouble answers the question "why do I have to type 'zvtmzu' to post a comment on your blog?!" Because of splogs & link farms. Blech. Jon Gordon on Future Tense interviewed Charles C. Mann,...